{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:21:58Z","timestamp":1772032918293,"version":"3.50.1"},"reference-count":276,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The nucleoprotein structures known as telomeres provide genomic integrity by protecting the ends of chromosomes. Tumorigenesis is associated with alterations in telomere function and stability. This narrative review provides evidence of the potential prognostic value of telomere length and telomerase in leukemias. On the one hand, oxidative stress and mitochondrial dysfunction can accelerate telomere shortening, leading to higher susceptibility and the progression of leukemia. On the other hand, cytogenetic alterations (such as gene fusions and chromosomal abnormalities) and genomic complexity can result from checkpoint dysregulation, the induction of the DNA damage response (DDR), and defective repair signaling at telomeres. This review thoroughly outlines the ways by which telomere dysfunction can play a key role in the development and progression of four primary leukemias, including chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), and acute leukemias of myeloid or lymphoid origin, highlighting the potential prognostic value of telomere length in this field. However, telomerase, which is highly active in leukemias, can prevent the rate of telomere attrition. In line with this, leukemia cells can proliferate, suggesting telomerase as a promising therapeutic target in leukemias. For this reason, telomerase-based immunotherapy is analyzed in the fight against leukemias, leveraging the immune system to eliminate leukemia cells with uncontrolled proliferation.<\/jats:p>","DOI":"10.3390\/cancers17121936","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:53:16Z","timestamp":1749559996000},"page":"1936","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Telomere Length Signature in Leukemias\u2014From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase"],"prefix":"10.3390","volume":"17","author":[{"given":"Stella","family":"Baliou","sequence":"first","affiliation":[{"name":"Laboratory of Toxicology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5737-3770","authenticated-orcid":false,"given":"Iordanis","family":"Pelagiadis","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, 71110 Heraklion, Greece"},{"name":"Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miruna-Maria","family":"Apetroaei","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-2205","authenticated-orcid":false,"given":"Elena","family":"Vakonaki","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-6176","authenticated-orcid":false,"given":"Andreea Leti\u021bia","family":"Arsene","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania"},{"name":"Marius Nasta Institute of Pneumophthisiology, 90, Viilor Street, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-3309","authenticated-orcid":false,"given":"Eleftheria","family":"Hatzidaki","sequence":"additional","affiliation":[{"name":"Department of Neonatology\/NICU, University Hospital of Heraklion, 71110 Heraklion, Greece"},{"name":"School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolis N.","family":"Tzatzarakis","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-5674","authenticated-orcid":false,"given":"Petros","family":"Ioannou","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3824-2462","authenticated-orcid":false,"given":"Aristides","family":"Tsatsakis","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-5110","authenticated-orcid":false,"given":"Eftichia","family":"Stiakaki","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, 71110 Heraklion, Greece"},{"name":"Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2006.04.044","article-title":"Recent Expansion of the Telomeric Complex in Rodents: Two Distinct POT1 Proteins Protect Mouse Telomeres","volume":"126","author":"Hockemeyer","year":"2006","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.aab3389","article-title":"Human Telomere Biology: A Contributory and Interactive Factor in Aging, Disease Risks, and Protection","volume":"350","author":"Blackburn","year":"2015","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.genet.41.110306.130350","article-title":"How Shelterin Protects Mammalian Telomeres","volume":"42","author":"Palm","year":"2008","journal-title":"Annu. Rev. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: The Protein Complex That Shapes and Safeguards Human Telomeres","volume":"19","year":"2005","journal-title":"Genes Dev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Apetroaei, M.-M., Fragkiadaki, P., Velescu, B.\u0218., Baliou, S., Renieri, E., Dinu-Pirvu, C.E., Dr\u0103g\u0103nescu, D., Vl\u0103sceanu, A.M., Nedea, M.I.I., and Udeanu, D.I. (2024). Pharmacotherapeutic Considerations on Telomere Biology: The Positive Effect of Pharmacologically Active Substances on Telomere Length. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147694"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","article-title":"Telomere Dysfunction in Ageing and Age-Related Diseases","volume":"24","author":"Rossiello","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.4161\/cc.6.20.4798","article-title":"Telomere Length Profiles in Humans: All Ends Are Not Equal","volume":"6","author":"Gilson","year":"2007","journal-title":"Cell Cycle"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ceb.2012.08.007","article-title":"A Three-State Model of Telomere Control over Human Proliferative Boundaries","volume":"24","author":"Cesare","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Baliou, S., Ioannou, P., Apetroaei, M.-M., Vakonaki, E., Fragkiadaki, P., Kirithras, E., Tzatzarakis, M.N., Arsene, A.L., Docea, A.O., and Tsatsakis, A. (2024). The Impact of the Mediterranean Diet on Telomere Biology: Implications for Disease Management-A Narrative Review. Nutrients, 16.","DOI":"10.3390\/nu16152525"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrc2440","article-title":"Living on a Break: Cellular Senescence as a DNA-Damage Response","volume":"8","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41586-019-0885-0","article-title":"Autophagic Cell Death Restricts Chromosomal Instability during Replicative Crisis","volume":"565","author":"Nassour","year":"2019","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2017.05.015","article-title":"Senescence in Health and Disease","volume":"169","author":"He","year":"2017","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","article-title":"The Central Role of DNA Damage in the Ageing Process","volume":"592","author":"Schumacher","year":"2021","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3324\/haematol.2011.057109","article-title":"ATM and Chronic Lymphocytic Leukemia: Mutations, and Not Only Deletions, Matter","volume":"97","author":"Rossi","year":"2012","journal-title":"Haematologica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/embor.2012.61","article-title":"Cancer Chromosomal Instability: Therapeutic and Diagnostic Challenges","volume":"13","author":"McGranahan","year":"2012","journal-title":"EMBO Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cuceu, C., Colicchio, B., Jeandidier, E., Junker, S., Plassa, F., Shim, G., Mika, J., Frenzel, M., Al Jawhari, M., and Hempel, W.M. (2018). Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability. Cancers, 10.","DOI":"10.3390\/cancers10070233"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tsatsakis, A. (2025). Telomeres Biomarkers of a Healthy Life and Successful Aging, Jenny Stanford Publishing.","DOI":"10.1201\/9781003568094"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global Burden of Hematologic Malignancies and Evolution Patterns over the Past 30 Years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1612702","DOI":"10.1155\/2022\/1612702","article-title":"The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030","volume":"2022","author":"Du","year":"2022","journal-title":"J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dong, C., Zhang, N., and Zhang, L. (2021). The Multi-Omic Prognostic Model of Oxidative Stress-Related Genes in Acute Myeloid Leukemia. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.722064"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/CM9.0000000000001628","article-title":"Oxidative Stress in Leukemia and Antioxidant Treatment","volume":"134","author":"Dong","year":"2021","journal-title":"Chin. Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: A Model Metastatic Disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000447076","article-title":"Leukemia","volume":"43","author":"Juliusson","year":"2016","journal-title":"Prog. Tumor Res."},{"key":"ref_24","first-page":"91","article-title":"The Role of Telomeres and Telomerase Complex in Haematological Neoplasia: The Length of Telomeres as a Marker of Carcinogenesis and Prognosis of Disease","volume":"111","year":"2010","journal-title":"Prague Med. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2011.09022.x","article-title":"Telomere Dysfunction and Its Role in Haematological Cancer","volume":"156","author":"Jones","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1197-1271","article-title":"Evidence for an Alternative Mechanism for Maintaining Telomere Length in Human Tumors and Tumor-Derived Cell Lines","volume":"3","author":"Bryan","year":"1997","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A Survey of Telomerase Activity in Human Cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gde.2015.06.004","article-title":"The Short and Long Telomere Syndromes: Paired Paradigms for Molecular Medicine","volume":"33","author":"Stanley","year":"2015","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cge.13526","article-title":"Telomeropathies: Etiology, Diagnosis, Treatment and Follow-up. Ethical and Legal Considerations","volume":"96","author":"Armando","year":"2019","journal-title":"Clin. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41525-021-00198-5","article-title":"Telomere Biology Disorders","volume":"6","author":"Kam","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1172\/JCI120851","article-title":"Long Telomeres and Cancer Risk: The Price of Cellular Immortality","volume":"129","author":"McNally","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly Recurrent TERT Promoter Mutations in Human Melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2013.11.005","article-title":"TERT Promoter Mutations in Cancer Development","volume":"24","author":"Heidenreich","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.beha.2007.03.007","article-title":"Cell Proliferation and Death: Forgotten Features of Chronic Lymphocytic Leukemia B Cells","volume":"20","author":"Chiorazzi","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Vasko, T., Kaifie, A., Stope, M., Kraus, T., and Ziegler, P. (2017). Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions. IJMS, 18.","DOI":"10.3390\/ijms18112267"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5507\/bp.2018.084","article-title":"Telomere Dynamics in Adult Hematological Malignancies","volume":"163","author":"Olbertova","year":"2019","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/bcmd.2001.0389","article-title":"Very Short Telomeres in the Peripheral Blood of Patients with X-Linked and Autosomal Dyskeratosis Congenita","volume":"27","author":"Vulliamy","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/302446","article-title":"X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene","volume":"65","author":"Knight","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_39","first-page":"1578","article-title":"[(Pan-)cytopenia as first manifestation of kryptic telomeropathies in adults]","volume":"141","author":"Schmitt","year":"2016","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00277-012-1454-x","article-title":"Telomere Elongation and Clinical Response to Androgen Treatment in a Patient with Aplastic Anemia and a Heterozygous hTERT Gene Mutation","volume":"91","author":"Ziegler","year":"2012","journal-title":"Ann. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2003-04-1345","article-title":"Telomere Length and Telomerase Activity Delineate Distinctive Replicative Features of the B-CLL Subgroups Defined by Immunoglobulin V Gene Mutations","volume":"103","author":"Damle","year":"2004","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41375-019-0446-4","article-title":"Short Telomeres Are Associated with Inferior Outcome, Genomic Complexity, and Clonal Evolution in Chronic Lymphocytic Leukemia","volume":"33","author":"Jebaraj","year":"2019","journal-title":"Leukemia"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zhang, J.-M., and Zou, L. (2020). Alternative Lengthening of Telomeres: From Molecular Mechanisms to Therapeutic Outlooks. Cell Biosci., 10.","DOI":"10.1186\/s13578-020-00391-6"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kent, T., Gracias, D., Shepherd, S., and Clynes, D. (2020). Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01518"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Dratwa, M., Wysocza\u0144ska, B., \u0141acina, P., Kubik, T., and Bogunia-Kubik, K. (2020). TERT-Regulation and Roles in Cancer Formation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.589929"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41467-023-37633-3","article-title":"Signalling Inhibition by Ponatinib Disrupts Productive Alternative Lengthening of Telomeres (ALT)","volume":"14","author":"Kusuma","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/gcc.20058","article-title":"Epigenetic Regulation of Human Telomerase Reverse Transcriptase Promoter Activity during Cellular Differentiation","volume":"41","author":"Liu","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/leu.2009.283","article-title":"Epigenetic Plasticity of hTERT Gene Promoter Determines Retinoid Capacity to Repress Telomerase in Maturation-Resistant Acute Promyelocytic Leukemia Cells","volume":"24","author":"Azouz","year":"2010","journal-title":"Leukemia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.trecan.2020.02.007","article-title":"Promoter DNA Hypermethylation and Paradoxical Gene Activation","volume":"6","author":"Smith","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V126.23.1267.1267","article-title":"Activity of the Telomerase Inhibitor GRN163L (Imetelstat) on Acute Myeloblastic Leukemia Blasts Is Enhanced by DNA Methyltransferase Inhibitors Irrespective of TERT Promoter Methylation Status","volume":"126","author":"Cantilena","year":"2015","journal-title":"Blood"},{"key":"ref_51","first-page":"3","article-title":"Mitochondrial Electron Transport Chain, ROS Generation and Uncoupling (Review)","volume":"44","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Theurey, P., and Pizzo, P. (2018). The Aging Mitochondria. Genes, 9.","DOI":"10.3390\/genes9010022"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1006\/jmcc.2001.1378","article-title":"Mitochondrial Dysfunction in Cardiac Disease: Ischemia--Reperfusion, Aging, and Heart Failure","volume":"33","author":"Lesnefsky","year":"2001","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.1992.tb27448.x","article-title":"Age-Dependent Changes in the Activity of Anion Carriers and in the Lipid Composition in Rat Heart Mitochondria","volume":"673","author":"Paradies","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lee, Y.H., Park, J.Y., Lee, H., Song, E.S., Kuk, M.U., Joo, J., Oh, S., Kwon, H.W., Park, J.T., and Park, S.C. (2021). Targeting Mitochondrial Metabolism as a Strategy to Treat Senescence. Cells, 10.","DOI":"10.3390\/cells10113003"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1038\/ncomms4792","article-title":"Endoplasmic Reticulum Calcium Release through ITPR2 Channels Leads to Mitochondrial Calcium Accumulation and Senescence","volume":"5","author":"Wiel","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Passos, J.F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C.J., Miwa, S., Olijslagers, S., Hallinan, J., and Wipat, A. (2010). Feedback between P21 and Reactive Oxygen Production Is Necessary for Cell Senescence. Mol. Syst. Biol., 6.","DOI":"10.1038\/msb.2010.5"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cell.2020.12.028","article-title":"Telomeres: History, Health, and Hallmarks of Aging","volume":"184","author":"Chakravarti","year":"2021","journal-title":"Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"18435","DOI":"10.1073\/pnas.1910574116","article-title":"Chemoptogenetic Damage to Mitochondria Causes Rapid Telomere Dysfunction","volume":"116","author":"Qian","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1474-9728.2002.00004.x","article-title":"Mitochondrial Dysfunction Leads to Telomere Attrition and Genomic Instability","volume":"1","author":"Liu","year":"2002","journal-title":"Aging Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1474-9728.2003.00040.x","article-title":"MitoQ Counteracts Telomere Shortening and Elongates Lifespan of Fibroblasts under Mild Oxidative Stress","volume":"2","author":"Saretzki","year":"2003","journal-title":"Aging Cell"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gouspillou, G., Sgarioto, N., Norris, B., Barbat-Artigas, S., Aubertin-Leheudre, M., Morais, J.A., Burelle, Y., Taivassalo, T., and Hepple, R.T. (2014). The Relationship between Muscle Fiber Type-Specific PGC-1\u03b1 Content and Mitochondrial Content Varies between Rodent Models and Humans. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103044"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature09787","article-title":"Telomere Dysfunction Induces Metabolic and Mitochondrial Compromise","volume":"470","author":"Sahin","year":"2011","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Assalve, G., Lunetti, P., Rocca, M.S., Cosci, I., Di Nisio, A., Ferlin, A., Zara, V., and Ferramosca, A. (2025). Exploring the Link Between Telomeres and Mitochondria: Mechanisms and Implications in Different Cell Types. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26030993"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-019-1100-5","article-title":"MRE11-RAD50-NBS1 Complex Alterations and DNA Damage Response: Implications for Cancer Treatment","volume":"18","author":"Bian","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12672-024-01538-4","article-title":"Decreased Mitochondrial Transcription Factor A and Mitochondrial DNA Copy Number Promote Cyclin-Dependent Kinase Inhibitor 1A Expression and Reduce Tumorigenic Properties of Colorectal Cancer Cells","volume":"15","author":"Buchwaldt","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1038\/ncomms5924","article-title":"Glucose Substitution Prolongs Maintenance of Energy Homeostasis and Lifespan of Telomere Dysfunctional Mice","volume":"5","author":"Missios","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/1389557517666170228115324","article-title":"Reactive Oxygen and Nitrogen Species in Carcinogenesis: Implications of Oxidative Stress on the Progression and Development of Several Cancer Types","volume":"17","author":"Kruk","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Chen, Y.-C., Lu, M.-C., El-Shazly, M., Lai, K.-H., Wu, T.-Y., Hsu, Y.-M., Lee, Y.-L., and Liu, Y.-C. (2018). Breaking down Leukemia Walls: Heteronemin, a Sesterterpene Derivative, Induces Apoptosis in Leukemia Molt4 Cells through Oxidative Stress, Mitochondrial Dysfunction and Induction of Talin Expression. Mar. Drugs, 16.","DOI":"10.3390\/md16060212"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"27263","DOI":"10.1074\/jbc.M113.479055","article-title":"Neil3 and NEIL1 DNA Glycosylases Remove Oxidative Damages from Quadruplex DNA and Exhibit Preferences for Lesions in the Telomeric Sequence Context","volume":"288","author":"Zhou","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinbiochem.2008.01.027","article-title":"Measurement of Oxidative Stress and Antioxidant Status in Acute Lymphoblastic Leukemia Patients","volume":"41","author":"Battisti","year":"2008","journal-title":"Clin. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.leukres.2009.04.038","article-title":"Does Oxidative Damage Contribute to the Generation of Leukemia?","volume":"33","author":"Austin","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1182\/blood-2011-01-326025","article-title":"Do Reactive Oxygen Species Play a Role in Myeloid Leukemias?","volume":"117","author":"Hole","year":"2011","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1074\/jbc.M110.103713","article-title":"Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia","volume":"285","author":"Zhou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00262-017-1969-z","article-title":"Upregulation of Thioredoxin-1 in Activated Human NK Cells Confers Increased Tolerance to Oxidative Stress","volume":"66","author":"Mimura","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-16-2426","article-title":"Jab1\/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress","volume":"23","author":"Zhou","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e6806","DOI":"10.1002\/cam4.6806","article-title":"Oxidative Stress Is Two-Sided in the Treatment of Acute Myeloid Leukemia","volume":"13","author":"Fan","year":"2024","journal-title":"Cancer Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1089\/ars.2008.2071","article-title":"Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications","volume":"10","author":"Rodrigues","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","article-title":"Rac2-MRC-cIII-Generated ROS Cause Genomic Instability in Chronic Myeloid Leukemia Stem Cells and Primitive Progenitors","volume":"119","author":"Kopinski","year":"2012","journal-title":"Blood"},{"key":"ref_80","first-page":"994","article-title":"Oxidative Stress as a Therapeutic Perspective for ATM-Deficient Chronic Lymphocytic Leukemia Patients","volume":"100","author":"Navrkalova","year":"2015","journal-title":"Haematologica"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1080\/01635581.2016.1235717","article-title":"Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria","volume":"68","author":"Salimi","year":"2016","journal-title":"Nutr. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/leu.2015.187","article-title":"Metabolic Plasticity in CLL: Adaptation to the Hypoxic Niche","volume":"30","author":"Koczula","year":"2016","journal-title":"Leukemia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1874609811205030006","article-title":"Telomere Shortening Is a Sole Mechanism of Aging in Mammals","volume":"5","author":"Mikhelson","year":"2012","journal-title":"Curr. Aging Sci."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Reichert, S., and Stier, A. (2017). Does Oxidative Stress Shorten Telomeres in vivo? A Review. Biol. Lett., 13.","DOI":"10.1098\/rsbl.2017.0463"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/smi.2607","article-title":"The Relationship Between Perceived Stress and Telomere Length: A Meta-analysis","volume":"32","author":"Schutte","year":"2016","journal-title":"Stress Health"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"180744","DOI":"10.1098\/rsos.180744","article-title":"Telomeres as Integrative Markers of Exposure to Stress and Adversity: A Systematic Review and Meta-Analysis","volume":"5","author":"Pepper","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s43042-022-00335-4","article-title":"Telomere Attrition and Inflammation: The Chicken and the Egg Story","volume":"23","author":"Niveta","year":"2022","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mad.2018.03.013","article-title":"The Impact of Oxidative DNA Damage and Stress on Telomere Homeostasis","volume":"177","author":"Barnes","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"17312","DOI":"10.1073\/pnas.0407162101","article-title":"Accelerated Telomere Shortening in Response to Life Stress","volume":"101","author":"Epel","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1196\/annals.1297.047","article-title":"Mechanism of Telomere Shortening by Oxidative Stress","volume":"1019","author":"Kawanishi","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Cadet, J., and Wagner, J.R. (2013). DNA Base Damage by Reactive Oxygen Species, Oxidizing Agents, and UV Radiation. Cold Spring Harb. Perspect. Biol., 5.","DOI":"10.1101\/cshperspect.a012559"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0968-0004(02)02110-2","article-title":"Oxidative Stress Shortens Telomeres","volume":"27","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1073\/pnas.92.10.4337","article-title":"Oxidative DNA Damage and Senescence of Human Diploid Fibroblast Cells","volume":"92","author":"Chen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Salehi, F., Behboudi, H., Kavoosi, G., and Ardestani, S.K. (2018). Oxidative DNA Damage Induced by ROS-Modulating Agents with the Ability to Target DNA: A Comparison of the Biological Characteristics of Citrus Pectin and Apple Pectin. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-32308-2"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nsmb.3319","article-title":"Oxidative Guanine Base Damage Regulates Human Telomerase Activity","volume":"23","author":"Fouquerel","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molcel.2019.04.024","article-title":"Targeted and Persistent 8-Oxoguanine Base Damage at Telomeres Promotes Telomere Loss and Crisis","volume":"75","author":"Fouquerel","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bpobgyn.2010.10.016","article-title":"Oxidative Stress","volume":"25","author":"Burton","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/nar\/gki273","article-title":"Oxidative Damage in Telomeric DNA Disrupts Recognition by TRF1 and TRF2","volume":"33","author":"Opresko","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2015-06-651125","article-title":"Long-Term Remissions after FCR Chemoimmunotherapy in Previously Untreated Patients with CLL: Updated Results of the CLL8 Trial","volume":"127","author":"Fischer","year":"2016","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41467-020-14829-5","article-title":"The Complex Genetic Landscape of Familial MDS and AML Reveals Pathogenic Germline Variants","volume":"11","author":"Vulliamy","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood-2016-01-691550","article-title":"Complex Karyotypes and KRAS and POT1 Mutations Impact Outcome in CLL after Chlorambucil-Based Chemotherapy or Chemoimmunotherapy","volume":"128","author":"Herling","year":"2016","journal-title":"Blood"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ncb1275","article-title":"DNA Processing Is Not Required for ATM-Mediated Telomere Damage Response after TRF2 Deletion","volume":"7","author":"Celli","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0960-9822(03)00542-6","article-title":"DNA Damage Foci at Dysfunctional Telomeres","volume":"13","author":"Takai","year":"2003","journal-title":"Curr. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.dnarep.2010.09.008","article-title":"Factors That Influence Telomeric Oxidative Base Damage and Repair by DNA Glycosylase OGG1","volume":"10","author":"Rhee","year":"2011","journal-title":"DNA Repair"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dnarep.2017.09.007","article-title":"Not Breathing Is Not an Option: How to Deal with Oxidative DNA Damage","volume":"59","author":"Markkanen","year":"2017","journal-title":"DNA Repair"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1242\/jcs.019372","article-title":"Telomerase Does Not Counteract Telomere Shortening but Protects Mitochondrial Function under Oxidative Stress","volume":"121","author":"Ahmed","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair Pathway Choices and Consequences at the Double-Strand Break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.131009198","article-title":"Single-Strand Interruptions in Replicating Chromosomes Cause Double-Strand Breaks","volume":"98","author":"Kuzminov","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.dnarep.2016.05.022","article-title":"DNA Damage Processing at Telomeres: The Ends Justify the Means","volume":"44","author":"Fouquerel","year":"2016","journal-title":"DNA Repair"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.csbj.2019.12.013","article-title":"The Genomics of Oxidative DNA Damage, Repair, and Resulting Mutagenesis","volume":"18","author":"Poetsch","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"101154","DOI":"10.1016\/j.arr.2020.101154","article-title":"Fight to the Bitter End: DNA Repair and Aging","volume":"64","author":"Chen","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.bjp.0702159","article-title":"The Mechanism of the Nitric Oxide-Mediated Enhancement of Tert-Butylhydroperoxide-Induced DNA Single Strand Breakage","volume":"125","author":"Guidarelli","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","article-title":"The Role of Cellular Reactive Oxygen Species in Cancer Chemotherapy","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1128\/MCB.23.13.4598-4610.2003","article-title":"Hydrogen Peroxide Triggers Nuclear Export of Telomerase Reverse Transcriptase via Src Kinase Family-Dependent Phosphorylation of Tyrosine 707","volume":"23","author":"Haendeler","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1474-9728.2004.00124.x","article-title":"Mitochondrial hTERT Exacerbates Free-Radical-Mediated mtDNA Damage","volume":"3","author":"Santos","year":"2004","journal-title":"Aging Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/asheducation-2016.1.149","article-title":"Prognostication of Chronic Lymphocytic Leukemia in the Era of New Agents","volume":"2016","author":"Eichhorst","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-397898-1.00006-2","article-title":"Telomere Dysfunction and Hematologic Disorders","volume":"Volume 125","author":"Paiva","year":"2014","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Ropio, J., Merlio, J.-P., Soares, P., and Chevret, E. (2016). Telomerase Activation in Hematological Malignancies. Genes, 7.","DOI":"10.3390\/genes7090061"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3324\/haematol.2011.049874","article-title":"Telomere Length and Telomerase Levels Delineate Subgroups of B-Cell Chronic Lymphocytic Leukemia with Different Biological Characteristics and Clinical Outcomes","volume":"97","author":"Rampazzo","year":"2012","journal-title":"Haematologica"},{"key":"ref_120","first-page":"4918","article-title":"Telomere Length and Telomerase Activity Predict Survival in Patients with B Cell Chronic Lymphocytic Leukemia","volume":"58","author":"Bechter","year":"1998","journal-title":"Cancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.leu.2404544","article-title":"Telomere Length Identifies Two Different Prognostic Subgroups among VH-Unmutated B-Cell Chronic Lymphocytic Leukemia Patients","volume":"21","author":"Ricca","year":"2007","journal-title":"Leukemia"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood-2007-05-092759","article-title":"Short Telomeres Are Associated with Genetic Complexity, High-Risk Genomic Aberrations, and Short Survival in Chronic Lymphocytic Leukemia","volume":"111","author":"Roos","year":"2008","journal-title":"Blood"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2008.399","article-title":"Telomere Length Is an Independent Predictor of Survival, Treatment Requirement and Richter\u2019s Syndrome Transformation in Chronic Lymphocytic Leukemia","volume":"23","author":"Rossi","year":"2009","journal-title":"Leukemia"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23466","article-title":"Short Telomere Length Is Associated with NOTCH1\/SF3B1\/TP53 Aberrations and Poor Outcome in Newly Diagnosed Chronic Lymphocytic Leukemia Patients","volume":"88","author":"Mansouri","year":"2013","journal-title":"Am. J. Hematol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/leu.2015.217","article-title":"Telomere Length Predicts Progression and Overall Survival in Chronic Lymphocytic Leukemia: Data from the UK LRF CLL4 Trial","volume":"29","author":"Strefford","year":"2015","journal-title":"Leukemia"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bjc.6600763","article-title":"Association between Telomere Length and V(H) Gene Mutation Status in Chronic Lymphocytic Leukaemia: Clinical and Biological Implications","volume":"88","author":"Hultdin","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404607","article-title":"Telomerase Expression in B-Cell Chronic Lymphocytic Leukemia Predicts Survival and Delineates Subgroups of Patients with the Same igVH Mutation Status and Different Outcome","volume":"21","author":"Terrin","year":"2007","journal-title":"Leukemia"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.yexmp.2017.05.010","article-title":"Prognostic Role of Telomere Length in Malignancies: A Meta-Analysis and Meta-Regression","volume":"102","author":"Adam","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/blood-2004-11-4394","article-title":"Telomere Length as a Prognostic Parameter in Chronic Lymphocytic Leukemia with Special Reference to VH Gene Mutation Status","volume":"105","author":"Grabowski","year":"2005","journal-title":"Blood"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Jebaraj, B.M.C., and Stilgenbauer, S. (2020). Telomere Dysfunction in Chronic Lymphocytic Leukemia. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.612665"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1182\/blood-2003-12-4412","article-title":"Telomere Length Correlates with Histopathogenesis According to the Germinal Center in Mature B-Cell Lymphoproliferative Disorders","volume":"103","author":"Ladetto","year":"2004","journal-title":"Blood"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2010-07-291443","article-title":"Telomere Disrupts, CLL Progresses","volume":"116","author":"Ladetto","year":"2010","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood-2010-02-272104","article-title":"Telomere Dysfunction and Fusion during the Progression of Chronic Lymphocytic Leukemia: Evidence for a Telomere Crisis","volume":"116","author":"Lin","year":"2010","journal-title":"Blood"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1080\/10428194.2017.1390236","article-title":"Telomere Length in Poor-Risk Chronic Lymphocytic Leukemia: Associations with Disease Characteristics and Outcome","volume":"59","author":"Steinbrecher","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1182\/blood-2015-09-667675","article-title":"Fludarabine, Cyclophosphamide, and Rituximab Treatment Achieves Long-Term Disease-Free Survival in IGHV-Mutated Chronic Lymphocytic Leukemia","volume":"127","author":"Thompson","year":"2016","journal-title":"Blood"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1182\/blood-2015-05-647925","article-title":"Molecular Prediction of Durable Remission after First-Line Fludarabine-Cyclophosphamide-Rituximab in Chronic Lymphocytic Leukemia","volume":"126","author":"Rossi","year":"2015","journal-title":"Blood"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Lazarian, G., Cymbalista, F., and Baran-Marszak, F. (2022). Impact of Low-Burden TP53 Mutations in the Management of CLL. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.841630"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bjh.13023","article-title":"Telomere Dysfunction Accurately Predicts Clinical Outcome in Chronic Lymphocytic Leukaemia, Even in Patients with Early Stage Disease","volume":"167","author":"Lin","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41375-019-0389-9","article-title":"Telomere Length Predicts for Outcome to FCR Chemotherapy in CLL","volume":"33","author":"Norris","year":"2019","journal-title":"Leukemia"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1007\/s13277-015-3556-2","article-title":"Telomere Shortening Associated with Increased Genomic Complexity in Chronic Lymphocytic Leukemia","volume":"36","author":"Panero","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/gcc.22171","article-title":"Relevance of Telomere\/Telomerase System Impairment in Early Stage Chronic Lymphocytic Leukemia","volume":"53","author":"Hoxha","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2011.02.002","article-title":"Importance of Genetics in Chronic Lymphocytic Leukemia","volume":"25","author":"Zenz","year":"2011","journal-title":"Blood Rev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations Driving CLL and Their Evolution in Progression and Relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Song, D.Y., Kim, J.-A., Jeong, D., Yun, J., Kim, S.-M., Lim, K., Park, S.N., Im, K., Choi, S., and Yoon, S.-S. (2019). Telomere Length and Its Correlation with Gene Mutations in Chronic Lymphocytic Leukemia in a Korean Population. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220177"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00277-017-3055-1","article-title":"Telomere Shortening, TP53 Mutations and Deletions in Chronic Lymphocytic Leukemia Result in Increased Chromosomal Instability and Breakpoint Clustering in Heterochromatic Regions","volume":"96","author":"Thomay","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"M\u2019kacher, R., Colicchio, B., Borie, C., Junker, S., Marquet, V., Heidingsfelder, L., Soehnlen, K., Najar, W., Hempel, W.M., and Oudrhiri, N. (2020). Telomere and Centromere Staining Followed by M-FISH Improves Diagnosis of Chromosomal Instability and Its Clinical Utility. Genes, 11.","DOI":"10.3390\/genes11050475"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Olbertova, H., Plevova, K., Pavlova, S., Malcikova, J., Kotaskova, J., Stranska, K., Spunarova, M., Trbusek, M., Navrkalova, V., and Dvorackova, B. (2022). Evolution of TP53 Abnormalities during CLL Disease Course Is Associated with Telomere Length Changes. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09221-z"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.cell.2015.11.054","article-title":"Chromothripsis and Kataegis Induced by Telomere Crisis","volume":"163","author":"Maciejowski","year":"2015","journal-title":"Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gde.2020.02.009","article-title":"Chromothripsis and Telomere Crisis: Engines of Genome Instability","volume":"60","author":"Dewhurst","year":"2020","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Wan Mohamad Zamri, W.N., Mohd Yunus, N., Abdul Aziz, A.A., Zulkipli, N.N., and Sulong, S. (2023). Perspectives on the Application of Cytogenomic Approaches in Chronic Lymphocytic Leukaemia. Diagnostics, 13.","DOI":"10.3390\/diagnostics13050964"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41375-021-01322-1","article-title":"Combined Analysis of IGHV Mutations, Telomere Length and CD49d Identifies Long-Term Progression-Free Survivors in TP53 Wild-Type CLL Treated with FCR-Based Therapies","volume":"36","author":"Pepper","year":"2022","journal-title":"Leukemia"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.V65.5.1039.1039","article-title":"Chronic Myelogenous Leukemia: Recent Advances","volume":"65","author":"Champlin","year":"1985","journal-title":"Blood"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","article-title":"The Biology of Cancer Stem Cells","volume":"23","author":"Lobo","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The Development of Imatinib as a Therapeutic Agent for Chronic Myeloid Leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.leu.2400560","article-title":"Telomerase Activity and Cytogenetic Changes in Chronic Myeloid Leukemia with Disease Progression","volume":"11","author":"Ohyashiki","year":"1997","journal-title":"Leukemia"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V95.6.1883","article-title":"Prognostic Implications of Differences in Telomere Length between Normal and Malignant Cells from Patients with Chronic Myeloid Leukemia Measured by Flow Cytometry","volume":"95","author":"Holyoake","year":"2000","journal-title":"Blood"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V96.1.358","article-title":"Telomere Length Shortening in Chronic Myelogenous Leukemia Is Associated with Reduced Time to Accelerated Phase","volume":"96","author":"Boultwood","year":"2000","journal-title":"Blood"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1080\/10428190410001693542","article-title":"Telomere Shortening Correlates with Prognostic Score at Diagnosis and Proceeds Rapidly during Progression of Chronic Myeloid Leukemia","volume":"45","author":"Drummond","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/leu.2015.245","article-title":"Telomere Length at Diagnosis of Chronic Phase Chronic Myeloid Leukemia (CML-CP) Identifies a Subgroup with Favourable Prognostic Parameters and Molecular Response According to the ELN Criteria after 12 Months of Treatment with Nilotinib","volume":"29","author":"Wenn","year":"2015","journal-title":"Leukemia"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2002-08-2557","article-title":"Telomere Length in Peripheral Blood Granulocytes Reflects Response to Treatment with Imatinib in Patients with Chronic Myeloid Leukemia","volume":"101","author":"Hartmann","year":"2003","journal-title":"Blood"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.92.20.9082","article-title":"Telomerase Activity in Normal and Malignant Hematopoietic Cells","volume":"92","author":"Broccoli","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","first-page":"610","article-title":"Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, Pre- and Post-Ex Vivo Culture","volume":"60","author":"Engelhardt","year":"2000","journal-title":"Cancer Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3892\/ol.2024.14557","article-title":"BTK Acts as a Modulator of the Response to Imatinib in Chronic Myeloid Leukemia","volume":"28","author":"Schmidlechner","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"14183","DOI":"10.1074\/jbc.272.22.14183","article-title":"Bcl-2 Modulates Telomerase Activity","volume":"272","author":"Mandal","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12672-024-01161-3","article-title":"Combination of BCL-2 Inhibitors and Immunotherapy: A Promising Therapeutic Strategy for Hematological Malignancies","volume":"15","author":"Peng","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Xu, J., Dong, X., Huang, D.C.S., Xu, P., Zhao, Q., and Chen, B. (2023). Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers. Cancers, 15.","DOI":"10.3390\/cancers15204957"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clml.2015.03.006","article-title":"Use of Second- and Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm","volume":"15","author":"Jabbour","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/bloodadvances.2018017772","article-title":"Telomere Shortening Correlates with Leukemic Stem Cell Burden at Diagnosis of Chronic Myeloid Leukemia","volume":"2","author":"Bouillon","year":"2018","journal-title":"Blood Adv."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.2003.tb03229.x","article-title":"Normalization of Previously Shortened Telomere Length under Treatment with Imatinib Argues against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Patients with Chronic Myeloid Leukemia","volume":"996","author":"Brummendorf","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.mad.2012.05.007","article-title":"Telomere Loss in Philadelphia-Negative Hematopoiesis after Successful Treatment of Chronic Myeloid Leukemia: Evidence for Premature Aging of the Myeloid Compartment","volume":"133","author":"Ferrero","year":"2012","journal-title":"Mech. Ageing Dev."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric Acute Lymphoblastic Leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic Basis of Acute Lymphoblastic Leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"JCO"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"da Mota, T.H.A., Camargo, R., Biojone, E.R., Guimar\u00e3es, A.F.R., Pittella-Silva, F., and de Oliveira, D.M. (2023). The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia. Genes, 14.","DOI":"10.3390\/genes14030691"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Iacobucci, I., Kimura, S., and Mullighan, C.G. (2021). Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia. JCM, 10.","DOI":"10.3390\/jcm10173792"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute Lymphoblastic Leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"ref_176","first-page":"328","article-title":"Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis","volume":"11","year":"2017","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/EDBK_175401","article-title":"Novel Therapeutics in Acute Myeloid Leukemia","volume":"37","author":"DiNardo","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1182\/blood.2021011694","article-title":"How I Treat Pediatric Acute Myeloid Leukemia","volume":"138","author":"Rubnitz","year":"2021","journal-title":"Blood"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2020.10.013","article-title":"The Genomic Landscape of Pediatric Acute Lymphoblastic Leukemia and Precision Medicine Opportunities","volume":"84","author":"Tran","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-020-00905-2","article-title":"Evolving Therapy of Adult Acute Lymphoblastic Leukemia: State-of-the-Art Treatment and Future Directions","volume":"13","author":"Samra","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Aberuyi, N., Rahgozar, S., Ghodousi, E.S., and Ghaedi, K. (2019). Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01496"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic Profiling of Adult and Pediatric B-Cell Acute Lymphoblastic Leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/0008-5472.BCD-19-0041","article-title":"Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia","volume":"1","author":"Waanders","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3324\/haematol.2015.141101","article-title":"New and Emerging Prognostic and Predictive Genetic Biomarkers in B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"101","author":"Moorman","year":"2016","journal-title":"Haematologica"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1751-553X.2009.01178.x","article-title":"Telomerase Activity and Telomere Length in Acute Leukemia: Correlations with Disease Progression, Subtypes and Overall Survival","volume":"32","author":"Wang","year":"2010","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exphem.2010.10.008","article-title":"Telomere Deregulations Possess Cytogenetic, Phenotype, and Prognostic Specificities in Acute Leukemias","volume":"39","author":"Capraro","year":"2011","journal-title":"Exp. Hematol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00277-007-0395-2","article-title":"Correlation of Telomerase Activity to Apoptosis and Survival in Adult Acute Lymphoblastic Leukemia: An Egyptian Single-Center Study","volume":"87","author":"Asfour","year":"2008","journal-title":"Ann. Hematol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.10593","article-title":"Hypermethylation of the Human Telomerase Catalytic Subunit (hTERT) Gene Correlates with Telomerase Activity","volume":"101","author":"Guilleret","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.exphem.2011.08.014","article-title":"hTERT Promoter Methylation and Telomere Length in Childhood Acute Lymphoblastic Leukemia: Associations with Immunophenotype and Cytogenetic Subgroup","volume":"39","author":"Cullman","year":"2011","journal-title":"Exp. Hematol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41409-019-0543-z","article-title":"Presence of Centromeric but Absence of Telomeric Group B KIR Haplotypes in Stem Cell Donors Improve Leukaemia Control after HSCT for Childhood ALL","volume":"54","author":"Babor","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","article-title":"Cytogenetics in Acute Leukemia","volume":"18","author":"Heerema","year":"2004","journal-title":"Blood Rev."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1046\/j.1365-2141.1998.00969.x","article-title":"Telomerase Activity and the Expression of Telomerase Components in Acute Myelogenous Leukaemia","volume":"102","author":"Xu","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_193","first-page":"307","article-title":"Telomere Length and hTERT Expression in Patients with Acute Myeloid Leukemia Correlates with Chromosomal Abnormalities","volume":"90","author":"Hartmann","year":"2005","journal-title":"Haematologica"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1080\/10428190400007508","article-title":"Evaluation of Telomerase mRNA (hTERT) in Childhood Acute Leukemia","volume":"45","author":"Cogulu","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.leukres.2016.07.013","article-title":"Telomere Length and Associations with Somatic Mutations and Clinical Outcomes in Acute Myeloid Leukemia","volume":"49","author":"Watts","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/ejh.13196","article-title":"Bone Marrow Mononuclear Cell Telomere Length in Acute Myeloid Leukaemia and High-Risk Myelodysplastic Syndrome","volume":"102","author":"Warny","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Song, B., Lou, J., Mu, L., Lu, X., Sun, J., and Tang, B. (2024). An Innovative Telomere-Associated Prognosis Model in AML: Predicting Immune Infiltration and Treatment Responsiveness. Curr. Med. Chem., Online ahead of print.","DOI":"10.2174\/0109298673334218241021044800"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute Inherited Bone Marrow Failure Syndrome Cohort after Fifteen Years of Follow-Up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.2019003264","article-title":"Cancer Spectrum and Outcomes in the Mendelian Short Telomere Syndromes","volume":"135","author":"Schratz","year":"2020","journal-title":"Blood"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.mayocp.2018.03.020","article-title":"Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside","volume":"93","author":"Mangaonkar","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2008.17.1033","article-title":"Accelerated Telomere Shortening Precedes Development of Therapy-Related Myelodysplasia or Acute Myelogenous Leukemia after Autologous Transplantation for Lymphoma","volume":"27","author":"Chakraborty","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428190109064585","article-title":"Telomere Dynamics in Myelodysplastic Syndromes and Acute Leukemic Transformation","volume":"42","author":"Ohyashiki","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0301-472X(02)00969-4","article-title":"Accelerated Telomere Length Shortening in Granulocytes: A Diagnostic Marker for Myeloproliferative Diseases","volume":"30","author":"Terasaki","year":"2002","journal-title":"Exp. Hematol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcmd.2007.08.002","article-title":"Identification and Functional Characterization of Novel Telomerase Variant Alleles in Japanese Patients with Bone-Marrow Failure Syndromes","volume":"40","author":"Junko","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bies.10229","article-title":"Stem Cells, Telomerase and Dyskeratosis Congenita","volume":"25","author":"Mason","year":"2003","journal-title":"Bioessays"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1182\/bloodadvances.2023010658","article-title":"Telomeric Repeat-Containing RNA Is Dysregulated in Acute Myeloid Leukemia","volume":"7","author":"Catto","year":"2023","journal-title":"Blood Adv."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Caslini, C., and Serna, A. (2023). Telomere Transcription in MLL-Rearranged Leukemia Cell Lines: Increased Levels of TERRA Associate with Lymphoid Lineage and Are Independent of Telomere Length and Ploidy. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030925"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0092-8674(89)90035-4","article-title":"The Human Telomere Terminal Transferase Enzyme Is a Ribonucleoprotein That Synthesizes TTAGGG Repeats","volume":"59","author":"Morin","year":"1989","journal-title":"Cell"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Mohamad Kamal, N.S., Safuan, S., Shamsuddin, S., and Foroozandeh, P. (2020). Aging of the Cells: Insight into Cellular Senescence and Detection Methods. Eur. J. Cell Biol., 99.","DOI":"10.1016\/j.ejcb.2020.151108"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/scbi.2000.0339","article-title":"Telomerase and Human Tumorigenesis","volume":"10","author":"Stewart","year":"2000","journal-title":"Semin. Cancer Biol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MOH.0000000000000252","article-title":"Telomerase in Hematologic Malignancies","volume":"23","author":"Bruedigam","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13046-015-0195-9","article-title":"Telomere Length and Telomerase Activity in Non-Small Cell Lung Cancer Prognosis: Clinical Usefulness of a Specific Telomere Status","volume":"34","author":"Pascua","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Karow, A., Haubitz, M., Oppliger Leibundgut, E., Helsen, I., Preising, N., Steiner, D., Dantonello, T.M., Ammann, R.A., Roessler, J., and Kartal-Kaess, M. (2021). Targeting Telomere Biology in Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136653"},{"key":"ref_215","first-page":"799","article-title":"Telomerase Activity in Human Acute Myelogenous Leukemia: Inhibition of Telomerase Activity by Differentiation-Inducing Agents","volume":"2","author":"Zhang","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbadis.2009.02.012","article-title":"Prostate Tumor-Initiating Cells: A New Target for Telomerase Inhibition Therapy?","volume":"1792","author":"Marian","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Baylie, T., Jemal, M., Baye, G., Getinet, M., Amare, G.A., Adugna, A., Abebaw, D., Hibstu, Z., Tegegne, B.A., and Gugsa, E. (2025). The Role of Telomere and Telomerase in Cancer and Novel Therapeutic Target: Narrative Review. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1542930"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3892\/ol.2020.11659","article-title":"Telomeres and Telomerase in Oncogenesis","volume":"20","author":"Trybek","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbadis.2009.01.014","article-title":"Targeting the Telosome: Therapeutic Implications","volume":"1792","author":"Folini","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1582-4934.2011.01279.x","article-title":"Targeting Telomerase-Expressing Cancer Cells","volume":"15","author":"Ouellette","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1038\/s41388-020-01405-w","article-title":"Targeting Telomerase for Cancer Therapy","volume":"39","author":"Guterres","year":"2020","journal-title":"Oncogene"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.onc.1205064","article-title":"Oligonucleotide N3\u2032-->P5\u2032 Phosphoramidates as Efficient Telomerase Inhibitors","volume":"21","author":"Herbert","year":"2002","journal-title":"Oncogene"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"120402","DOI":"10.1016\/j.lfs.2022.120402","article-title":"Telomerase Inhibition on Acute Myeloid Leukemia Stem Cell Induced Apoptosis with Both Intrinsic and Extrinsic Pathways","volume":"295","author":"Rafat","year":"2022","journal-title":"Life Sci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.stem.2014.11.014","article-title":"Pushing the Limits: Defeating Leukemia Stem Cells by Depleting Telomerase","volume":"15","author":"Kuo","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"e70076","DOI":"10.1111\/cts.70076","article-title":"Imetelstat, a Novel, First-in-Class Telomerase Inhibitor: Mechanism of Action, Clinical, and Translational Science","volume":"17","author":"Lennox","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/14656566.2025.2471518","article-title":"Examining the Safety and Efficacy of Imetelstat in Low-Risk Myelodysplastic Syndrome","volume":"26","author":"Thomas","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1200\/JCO.20.01895","article-title":"Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients with Lower-Risk Myelodysplastic Syndromes in a Phase II Study","volume":"39","author":"Steensma","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_228","unstructured":"(2025, June 01). Imetelstat FDA Approval, Available online: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-Imetelstat-low-intermediate-1-risk-myelodysplastic-syndromes-transfusion-dependent."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/bloodadvances.2023009903","article-title":"Telomerase-Targeted Therapies in Myeloid Malignancies","volume":"7","author":"Waksal","year":"2023","journal-title":"Blood Adv."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa1310523","article-title":"A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis","volume":"373","author":"Tefferi","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMe1508740","article-title":"Treating Myeloproliferation--On Target or Off?","volume":"373","author":"Armanios","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMoa1503479","article-title":"Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia","volume":"373","author":"Baerlocher","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10245332.2016.1275426","article-title":"Inhibition of Telomerase Using BIBR1532 Enhances Doxorubicin-Induced Apoptosis in Pre-B Acute Lymphoblastic Leukemia Cells","volume":"22","author":"Bashash","year":"2017","journal-title":"Hematology"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1096\/fj.201902651RR","article-title":"A Small Molecule Compound IX Inhibits Telomere and Attenuates Oncogenesis of Drug-Resistant Leukemia Cells","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-60327-070-0_14","article-title":"Telomerase Inhibition Combined with Other Chemotherapeutic Reagents to Enhance Anti-Cancer Effect","volume":"405","author":"Tauchi","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.biopha.2018.07.140","article-title":"The Telomerase Inhibitor MST-312 Synergistically Enhances the Apoptotic Effect of Doxorubicin in Pre-B Acute Lymphoblastic Leukemia Cells","volume":"106","author":"Ghasemimehr","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","article-title":"Roles of Telomeres and Telomerase in Cancer, and Advances in Telomerase-Targeted Therapies","volume":"8","author":"Jafri","year":"2016","journal-title":"Genome Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/79519","article-title":"Induction of Cytotoxic T Cell Responses and Tumor Immunity against Unrelated Tumors Using Telomerase Reverse Transcriptase RNA Transfected Dendritic Cells","volume":"6","author":"Nair","year":"2000","journal-title":"Nat. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.cgt.7700563","article-title":"Dendritic Cells Reconstituted with Human Telomerase Gene Induce Potent Cytotoxic T-Cell Response against Different Types of Tumors","volume":"10","author":"Frolkis","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12935-024-03624-7","article-title":"Telomerase-Based Vaccines: A Promising Frontier in Cancer Immunotherapy","volume":"24","author":"Vahidi","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/j.vaccine.2017.09.011","article-title":"Telomerase Based Anticancer Immunotherapy and Vaccines Approaches","volume":"35","author":"Kailashiya","year":"2017","journal-title":"Vaccine"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.21037\/tcr-24-196","article-title":"Clinical Research Progress of Telomerase Targeted Cancer Immunotherapy: A Literature Review","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Pateras, I.S., Kotsakis, A., Avgeris, M., Baliou, E., Kouroupakis, P., Patsea, E., Georgoulias, V., Menez-Jamet, J., Kinet, J.-P., and Kosmatopoulos, K. (2021). Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in \u201cImmune Desert\u201d NSCLC. Cancers, 13.","DOI":"10.3390\/cancers13071658"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12967-021-02905-3","article-title":"NIPU: A Randomised, Open-Label, Phase II Study Evaluating Nivolumab and Ipilimumab Combined with UV1 Vaccination as Second Line Treatment in Patients with Malignant Mesothelioma","volume":"19","author":"Haakensen","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Aamdal, E., Inderberg, E.M., Ellingsen, E.B., Rasch, W., Brunsvig, P.F., Aamdal, S., Heintz, K.-M., Vod\u00e1k, D., Nakken, S., and Hovig, E. (2021). Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma\u2014Five-Year Follow Up of a Phase I\/IIa Trial. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.663865"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Rebucci-Peixoto, M., Vienot, A., Adotevi, O., Jacquin, M., Ghiringhelli, F., de la Fouchardi\u00e8re, C., You, B., Maurina, T., Kalbacher, E., and Bazan, F. (2022). A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.957580"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Greten, T.F., Forner, A., Korangy, F., N\u2019Kontchou, G., Barget, N., Ayuso, C., Ormandy, L.A., Manns, M.P., Beaugrand, M., and Bruix, J. (2010). A Phase II Open Label Trial Evaluating Safety and Efficacy of a Telomerase Peptide Vaccination in Patients with Advanced Hepatocellular Carcinoma. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-209"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/sj.bjc.6603437","article-title":"Telomerase Peptide Vaccination of Patients with Non-Resectable Pancreatic Cancer: A Dose Escalating Phase I\/II Study","volume":"95","author":"Bernhardt","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00262-006-0145-7","article-title":"Telomerase Peptide Vaccination: A Phase I\/II Study in Patients with Non-Small Cell Lung Cancer","volume":"55","author":"Brunsvig","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_250","first-page":"3202","article-title":"GV1001 Interacts with Androgen Receptor to Inhibit Prostate Cell Proliferation in Benign Prostatic Hyperplasia by Regulating Expression of Molecules Related to Epithelial-Mesenchymal Transition","volume":"13","author":"Kim","year":"2021","journal-title":"Aging (Albany N. Y.)"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/jnci\/djq145","article-title":"Telomerase-Based Therapies Emerging Slowly","volume":"102","author":"Brower","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4161\/onci.20426","article-title":"Widespread CD4+ T-Cell Reactivity to Novel hTERT Epitopes Following Vaccination of Cancer Patients with a Single hTERT Peptide GV1001","volume":"1","author":"Trachsel","year":"2012","journal-title":"Oncoimmunology"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mrfmmm.2011.07.006","article-title":"Is Telomerase a Viable Target in Cancer?","volume":"730","author":"Buseman","year":"2012","journal-title":"Mutat. Res."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jcyt.2018.09.007","article-title":"Empowering Dendritic Cell Cancer Vaccination: The Role of Combinatorial Strategies","volume":"20","author":"Galati","year":"2018","journal-title":"Cytotherapy"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.4161\/21645515.2014.982996","article-title":"Tumor Cell Lysates as Immunogenic Sources for Cancer Vaccine Design","volume":"10","author":"Gleisner","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_256","first-page":"893","article-title":"[Human telomerase reverse transcriptase as a novel target for tumor immunotherapy]","volume":"22","author":"Pang","year":"2003","journal-title":"Ai Zheng"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1479-5876-7-18","article-title":"Generation in Vivo of Peptide-Specific Cytotoxic T Cells and Presence of Regulatory T Cells during Vaccination with hTERT (Class I and II) Peptide-Pulsed DCs","volume":"7","author":"Aloysius","year":"2009","journal-title":"J. Transl. Med."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/cncr.30696","article-title":"Immune Responses and Long-Term Disease Recurrence Status after Telomerase-Based Dendritic Cell Immunotherapy in Patients with Acute Myeloid Leukemia","volume":"123","author":"Khoury","year":"2017","journal-title":"Cancer"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0022-3859.138797","article-title":"Telomeres and Telomerase: Understanding Basic Structure and Potential New Therapeutic Strategies Targeting It in the Treatment of Cancer","volume":"60","author":"Sekhri","year":"2014","journal-title":"J. Postgrad. Med."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1074-7613(00)80066-7","article-title":"The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes","volume":"10","author":"Vonderheide","year":"1999","journal-title":"Immunity"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1073\/pnas.070560797","article-title":"Cytotoxic T Cell Immunity against Telomerase Reverse Transcriptase in Humans","volume":"97","author":"Minev","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.exphem.2006.10.006","article-title":"Telomerase (hTERT 611-626) Serves as a Tumor Antigen in B-Cell Chronic Lymphocytic Leukemia and Generates Spontaneously Antileukemic, Cytotoxic T Cells","volume":"35","author":"Kokhaei","year":"2007","journal-title":"Exp. Hematol."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Barbullushi, K., Rampi, N., Serpenti, F., Scium\u00e8, M., Fabris, S., De Roberto, P., and Fracchiolla, N.S. (2022). Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?. Cancers, 14.","DOI":"10.3390\/cancers14122994"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.174.6.3798","article-title":"Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer","volume":"174","author":"Su","year":"2005","journal-title":"J. Immunol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"e1249090","DOI":"10.1080\/2162402X.2016.1249090","article-title":"T-Helper Cell Receptors from Long-Term Survivors after Telomerase Cancer Vaccination for Use in Adoptive Cell Therapy","volume":"5","author":"Kyte","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/1078-0432.CCR-0620-3","article-title":"Vaccination of Cancer Patients against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes","volume":"10","author":"Vonderheide","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1158\/0008-5472.CAN-04-2991","article-title":"Artificial Antigen-Presenting Cells Transduced with Telomerase Efficiently Expand Epitope-Specific, Human Leukocyte Antigen-Restricted Cytotoxic T Cells","volume":"65","author":"Dupont","year":"2005","journal-title":"Cancer Res."},{"key":"ref_268","first-page":"3","article-title":"[Suicide rates, suicide methods and uncertain cause of death in the elderly]","volume":"24","author":"Schmidtke","year":"1991","journal-title":"Z. Gerontol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood.V116.21.2190.2190","article-title":"Prolonged Administration of the Telomerase Vaccine GRNVAC1 Is Well Tolerated and Appears to Be Associated with Favorable Outcomes In High-Risk Acute Myeloid Leukemia (AML)","volume":"116","author":"Khoury","year":"2010","journal-title":"Blood"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ctrv.2012.06.007","article-title":"Novel Anticancer Therapeutics Targeting Telomerase","volume":"39","author":"Ruden","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13045-017-0459-2","article-title":"Vaccination with Poly(IC:LC) and Peptide-Pulsed Autologous Dendritic Cells in Patients with Pancreatic Cancer","volume":"10","author":"Mehrotra","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1158\/2326-6066.CIR-13-0001","article-title":"Highly Optimized DNA Vaccine Targeting Human Telomerase Reverse Transcriptase Stimulates Potent Antitumor Immunity","volume":"1","author":"Yan","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"e1083670","DOI":"10.1080\/2162402X.2015.1083670","article-title":"Anticancer DNA Vaccine Based on Human Telomerase Reverse Transcriptase Generates a Strong and Specific T Cell Immune Response","volume":"5","author":"Thalmensi","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4161\/21645515.2014.980686","article-title":"DNA Vaccine for Cancer Immunotherapy","volume":"10","author":"Yang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Lu, B., Lim, J.M., Yu, B., Song, S., Neeli, P., Sobhani, N., K, P., Bonam, S.R., Kurapati, R., and Zheng, J. (2024). The Next-Generation DNA Vaccine Platforms and Delivery Systems: Advances, Challenges and Prospects. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1332939"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12032-023-02060-3","article-title":"The Future of Cancer Immunotherapy: DNA Vaccines Leading the Way","volume":"40","author":"Pandya","year":"2023","journal-title":"Med. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/12\/1936\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:49:43Z","timestamp":1760032183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/12\/1936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":276,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["cancers17121936"],"URL":"https:\/\/doi.org\/10.3390\/cancers17121936","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}